SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genta, Inc. (GNTA)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1870 44 0 GNTA
Emcee:  John Nobrega Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1845Roy presentation (lecture) was not on regular schedule for Friday. It must be laMiljenko Zuanic-11/12/2004
1844Aventis terminated the relationship with GNTA. what do you guys make of it? GNTAgo_bucks-11/8/2004
1843Public release date: 1-Oct-2004 [ Print This Article | Close This Window ] ContJohn William Anderson-10/3/2004
1842>>Clinical Cancer Research Vol. 10, 5048-5057, August 1, 2004 A Phase I Ptuck-8/8/2004
1841Despite setbacks, Genta tries to prove it's one biotech company that can rebKen S.-7/7/2004
1840Re: High Bcl-2 expression in melanoma. My understanding is that the Bcl-2 factoArt Bechhoefer-7/5/2004
1839Despite setbacks, Genta tries to prove it's one biotech company that can rebKen S.-7/1/2004
1838IF Genasense is not working at all (for any indication) WHY NCI started large AMMiljenko Zuanic-6/28/2004
1837GNTA related abstract from ASCO Evaluation of Bcl-2 expression in melanoma - A NRugg-6/8/2004
1836FDA's Kiss of Life Motley Fool Wednesday June 2, 4:20 pm ET By W.D. CrottyKen S.-6/4/2004
1835Bob, I'll check the most recent ISIS annual report and get back to you. ArtArt Bechhoefer-6/2/2004
1834as far as i can tell, the only isis compound being tested as a combo is affinitabob zagorin-6/2/2004
1833Bob, yes, ISIS is now testing its drugs (most of them, anyway) in combination wiArt Bechhoefer-6/2/2004
1832thank you art.. are you sure about the isis cocktail approach? i wasn't awarbob zagorin-6/2/2004
1831Bob, as I understand it, the second generation antisense compounds target types Art Bechhoefer-6/2/2004
1830art, i have been in and out of gnta for about 8 yrs and i do think antisense hasbob zagorin-6/2/2004
1829The bias that may have been introduced by testing the control group earlier coulArt Bechhoefer-6/1/2004
1828The only results that have been made public are from the incomplete testing of GArt Bechhoefer-6/1/2004
1827Genasense Progression-Free Survival Data Do Not Show “Real Effect,” Cmte. Says Ken S.-5/31/2004
1826I see this as "punch back" to FDA stupidity. Miljenko [eom]Miljenko Zuanic-5/28/2004
1825Genta and Aventis Announce Termination of Genasense(TM) Expanded Access Program Ken S.-5/28/2004
1824Yes, I see that now, I was assuming, wrongly, it appears, that they were still gtom pope-5/25/2004
1823If the patients in the Genasense and control group were both actually improving,BulbaMan-5/25/2004
1822What I was thinking, and it must be that I'm overlooking something obvious, tom pope-5/25/2004
1821Tom, I'm not sure the question. I found this statistical fluke (or purposefrkrw-5/25/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News